Foxc1 establishes enhancer accessibility for craniofacial cartilage differentiation.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
27 01 2021
Historique:
received: 29 09 2020
accepted: 26 01 2021
pubmed: 28 1 2021
medline: 29 1 2022
entrez: 27 1 2021
Statut: epublish

Résumé

The specification of cartilage requires Sox9, a transcription factor with broad roles for organogenesis outside the skeletal system. How Sox9 and other factors gain access to cartilage-specific cis-regulatory regions during skeletal development was unknown. By analyzing chromatin accessibility during the differentiation of neural crest cells into chondrocytes of the zebrafish head, we find that cartilage-associated chromatin accessibility is dynamically established. Cartilage-associated regions that become accessible after neural crest migration are co-enriched for Sox9 and Fox transcription factor binding motifs. In zebrafish lacking Foxc1 paralogs, we find a global decrease in chromatin accessibility in chondrocytes, consistent with a later loss of dorsal facial cartilages. Zebrafish transgenesis assays confirm that many of these Foxc1-dependent elements function as enhancers with region- and stage-specific activity in facial cartilages. These results show that Foxc1 promotes chondrogenesis in the face by establishing chromatin accessibility at a number of cartilage-associated gene enhancers. Animals with backbones (or vertebrates) have body shape determined, in part, by their skeletons. These emerge in the embryo in the form of cartilage structures that will then get replaced by bone during development. The neural crest is a group of embryonic cells that can become different tissues. In the head, it forms the cartilage scaffold for some of the facial bones and the base of the skull. During this process, a protein called Sox9 is required for neural crest cells to morph into cartilage. This transcription factor binds to regulatory sequences in the genome to turn cartilage genes on. But Sox9 is also required to form non-cartilage tissues in organs such as the liver, lung, and kidneys. How, then, does Sox9 only turn on the genes required for cartilage formation in the embryonic face? This specificity can be controlled by which regulatory sequences Sox9 can physically access in a cell: controlling which regulatory sequences Sox9 can access determines which genes it can activate, and which type of tissue a cell will become. Xu, Yu et al. wanted to understand exactly how Sox9 switches on the genes that turn neural crest cells into facial cartilage. They studied the genomes of zebrafish embryos, which have a cartilaginous skeleton similar to other vertebrates, and found out which areas were accessible to transcription factors in the neural crest cells that became facial cartilage. Analyzing these regions suggested that sites where Sox9 could bind were often close to binding sites for another protein, called Foxc1. When zebrafish embryos were genetically modified to inactivate Foxc1 proteins, many of the regulatory sequences in cartilage failed to become accessible, and the cartilaginous skeleton did not form properly. These results support a model in which Foxc1 opens up the genomic regions that Sox9 needs to bind for cartilage to form, as opposed to the regions that Sox9 would bind to make different organ cell types. The findings of Xu, Yu et al. uncover the stepwise process by which cartilage cells are made during development. Further research based on these results could allow scientists to develop new ways of replacing cartilage in degenerative conditions such as arthritis.

Autres résumés

Type: plain-language-summary (eng)
Animals with backbones (or vertebrates) have body shape determined, in part, by their skeletons. These emerge in the embryo in the form of cartilage structures that will then get replaced by bone during development. The neural crest is a group of embryonic cells that can become different tissues. In the head, it forms the cartilage scaffold for some of the facial bones and the base of the skull. During this process, a protein called Sox9 is required for neural crest cells to morph into cartilage. This transcription factor binds to regulatory sequences in the genome to turn cartilage genes on. But Sox9 is also required to form non-cartilage tissues in organs such as the liver, lung, and kidneys. How, then, does Sox9 only turn on the genes required for cartilage formation in the embryonic face? This specificity can be controlled by which regulatory sequences Sox9 can physically access in a cell: controlling which regulatory sequences Sox9 can access determines which genes it can activate, and which type of tissue a cell will become. Xu, Yu et al. wanted to understand exactly how Sox9 switches on the genes that turn neural crest cells into facial cartilage. They studied the genomes of zebrafish embryos, which have a cartilaginous skeleton similar to other vertebrates, and found out which areas were accessible to transcription factors in the neural crest cells that became facial cartilage. Analyzing these regions suggested that sites where Sox9 could bind were often close to binding sites for another protein, called Foxc1. When zebrafish embryos were genetically modified to inactivate Foxc1 proteins, many of the regulatory sequences in cartilage failed to become accessible, and the cartilaginous skeleton did not form properly. These results support a model in which Foxc1 opens up the genomic regions that Sox9 needs to bind for cartilage to form, as opposed to the regions that Sox9 would bind to make different organ cell types. The findings of Xu, Yu et al. uncover the stepwise process by which cartilage cells are made during development. Further research based on these results could allow scientists to develop new ways of replacing cartilage in degenerative conditions such as arthritis.

Identifiants

pubmed: 33501917
doi: 10.7554/eLife.63595
pii: 63595
pmc: PMC7891931
doi:
pii:

Substances chimiques

Forkhead Transcription Factors 0
Foxc1a protein, zebrafish 0
Foxc1b protein, zebrafish 0
Zebrafish Proteins 0

Banques de données

GEO
['GSE157575']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDCR NIH HHS
ID : K99 DE029858
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC015829
Pays : United States
Organisme : NIDCR NIH HHS
ID : R35 DE027550
Pays : United States
Organisme : NIDCD NIH HHS
ID : T32 DC009975
Pays : United States

Informations de copyright

© 2021, Xu et al.

Déclaration de conflit d'intérêts

PX, HY, KT, MF, PF, NS, JC No competing interests declared

Références

J Anat. 2008 May;212(5):603-11
pubmed: 18422524
Nat Genet. 1999 May;22(1):85-9
pubmed: 10319868
Dev Cell. 2012 May 15;22(5):927-39
pubmed: 22595668
Dev Biol. 2006 Apr 1;292(1):174-88
pubmed: 16499899
Mol Cell Biol. 1997 Apr;17(4):2336-46
pubmed: 9121483
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Development. 2018 Jun 26;145(12):
pubmed: 29777011
Dev Cell. 2018 Dec 3;47(5):608-628.e6
pubmed: 30513303
Dev Biol. 2003 Oct 1;262(1):75-87
pubmed: 14512019
Dev Cell. 2012 Mar 13;22(3):597-609
pubmed: 22421045
Development. 2017 Aug 15;144(16):2994-3005
pubmed: 28705894
Development. 2016 Jun 15;143(12):2066-76
pubmed: 27122168
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24876-24884
pubmed: 32958671
Science. 2016 Feb 5;351(6273):613-7
pubmed: 26912704
Development. 2013 Mar;140(5):1034-44
pubmed: 23344708
Hum Mol Genet. 1999 Apr;8(4):625-37
pubmed: 10072431
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Development. 1997 Aug;124(15):2945-60
pubmed: 9247337
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell. 2002 Feb;9(2):279-89
pubmed: 11864602
Cell Rep. 2015 Jul 14;12(2):229-43
pubmed: 26146088
Dev Dyn. 2007 Nov;236(11):3088-99
pubmed: 17937395
Dev Biol. 2010 Apr 15;340(2):438-49
pubmed: 20123092
PLoS Genet. 2013;9(12):e1003949
pubmed: 24385915
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Nat Commun. 2015 Mar 26;6:6653
pubmed: 25808752
Genes Dis. 2014 Dec;1(2):149-161
pubmed: 25685828
Development. 2003 Apr;130(7):1353-65
pubmed: 12588851
Development. 2006 Feb;133(4):651-62
pubmed: 16421188
Dev Cell. 2015 Nov 9;35(3):358-65
pubmed: 26555055
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Dev Cell. 2018 Feb 5;44(3):337-347.e5
pubmed: 29358039
Genome Biol. 2008;9(9):R137
pubmed: 18798982
BMC Dev Biol. 2015 Nov 06;15:40
pubmed: 26545946
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Cell. 1998 Jun 12;93(6):985-96
pubmed: 9635428
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9360-5
pubmed: 12878728
Development. 2008 Dec;135(24):4059-69
pubmed: 19004856
Development. 2018 Jul 18;145(14):
pubmed: 30021842
Genes Dev. 2020 Aug 1;34(15-16):1039-1050
pubmed: 32561546
Development. 2005 Mar;132(5):1069-83
pubmed: 15689370
Dev Biol. 2009 Sep 15;333(2):324-36
pubmed: 19591819
PLoS Genet. 2016 Apr 08;12(4):e1005967
pubmed: 27058748
Dev Dyn. 2006 Dec;235(12):3199-212
pubmed: 17013879
Elife. 2021 Jan 27;10:
pubmed: 33501917

Auteurs

Pengfei Xu (P)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Haoze V Yu (HV)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Kuo-Chang Tseng (KC)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Mackenzie Flath (M)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Peter Fabian (P)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Neil Segil (N)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

J Gage Crump (JG)

Eli and Edythe Broad Center for Regenerative Medicine, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH